| Symbol |
LAMA2 |
| Full Name |
Laminin Subunit Alpha 2 |
| Chromosome |
6q22.33 |
| NCBI Gene |
3908 |
| Ensembl |
ENSG00000196559 |
| OMIM |
156225 |
| UniProt |
P24071 |
| Diseases |
[Congenital Muscular Dystrophy](/diseases/congenital-muscular-dystrophy), Merosin-Deficient Muscular Dystrophy, [Peripheral Neuropathy](/diseases/peripheral-neuropathy) |
| Expression |
Skeletal Muscle, Peripheral Nerve, Brain |
LAMA2 (Laminin Subunit Alpha 2) encodes the laminin alpha-2 chain, a critical component of the extracellular matrix. Laminin-211 (merosin), composed of alpha-2, beta-1, and gamma-1 chains, is essential for maintaining the structural integrity of skeletal muscle, peripheral nerve myelin sheaths, and the central nervous system. This page covers LAMA2's normal cellular functions, disease associations, and therapeutic implications [lamarelated2019].
¶ Gene Structure and Protein
The LAMA2 gene is located on chromosome 6q22.33 and encodes a massive 3,128-amino acid protein. The laminin alpha-2 chain is one of the largest extracellular matrix proteins and contains:
- N-terminal domain: Involved in chain assembly and polymerization
- Globular domains: Six globular (G) domains that interact with cell surface receptors
- Coiled-coil domains: Form the long arm that trimerizes with beta and gamma chains
- C-terminal laminin G domains: Bind to integrins (particularly α7β1 and α6β1), dystroglycan, and nidogen
Laminin-211 forms a critical bridge between the extracellular matrix and the cytoskeleton through the dystrophin-glycoprotein complex.
Laminin-211 is a key component of the basement membrane in muscle and nerve:
- Basement membrane formation: Self-polymerizes to form a network scaffold
- Cell surface attachment: Binds to integrins on muscle fibers and Schwann cells
- Dystrophin-glycoprotein complex connection: Links extracellular matrix to the intracellular cytoskeleton
- Signaling platform: Activates intracellular signaling pathways through receptor interactions
In the peripheral nerve, laminin-211 is essential for [mros2010]:
- Schwann cell survival: Supports Schwann cell viability and function
- Myelination: Critical for proper myelin sheath formation and maintenance
- Axonal support: Provides structural guidance for axons
- Node of Ranvier organization: Maintains proper distribution of nodal proteins
Laminin-211 in the brain contributes to [mros2010]:
- White matter integrity: Supports oligodendrocyte function and myelination
- Blood-brain barrier: Contributes to BBB maintenance through astrocyte interactions [mine2018]
- Synaptic organization: Regulates synapse formation and maintenance
LAMA2 exhibits tissue-specific expression:
- Skeletal muscle: Highest expression in muscle fibers, particularly in the basal lamina
- Peripheral nerve: Schwann cells, particularly in the Remak bundles and myelinating Schwann cells
- Brain: White matter, astrocytes, and cerebral blood vessels
- Heart: Cardiomyocytes
- Skin: Dermal fibroblasts
- Diaphragm: Respiratory muscles
Expression is highest during development and remains substantial in adult tissues.
LAMA2 mutations cause congenital muscular dystrophy (CMD), characterized by [kuang2015]:
- Muscle weakness: Present at birth or in early infancy, ranging from severe to mild
- Joint contractures: Restricted movement at joints (arthrogryposis)
- Respiratory insufficiency: Due to diaphragm and intercostal muscle involvement
- Cognitive impairment: Some patients have learning disabilities and intellectual disability
- White matter abnormalities: Visible on MRI brain imaging
The mechanism involves loss of laminin-211 in the extracellular matrix, disrupting the dystrophin-glycoprotein complex and causing muscle fiber instability.
Partial LAMA2 mutations lead to merosin-deficient muscular dystrophy:
- Later onset: Symptoms may appear in childhood or adolescence
- Reduced protein function: Residual laminin-211 activity
- Variable severity: Ranges from ambulatory to requiring wheelchair
- CK elevation: Elevated creatine kinase in serum
LAMA2 is critical for peripheral nerve myelination [cheng2012]:
- Demyelinating neuropathy: Similar to Charcot-Marie-Tooth disease
- Slow nerve conduction velocities: Reduced conduction velocity on electrophysiology
- Sensory loss: Reduced sensation in extremities
- Motor weakness: Distal muscle weakness and atrophy
LAMA2 deficiency affects the CNS through:
- White matter abnormalities: Impaired myelination visible on MRI
- Seizures: Higher incidence in LAMA2-deficient patients
- Cognitive development: Variable effects on cognitive function
- Hydrocephalus: Rare cases of hydrocephalus have been reported
Laminin-211 connects to the intracellular cytoskeleton through the dystrophin-glycoprotein complex:
[Extracellular Matrix] → Laminin-211 → Dystroglycan → Dystrophin → Actin Cytoskeleton
This connection provides mechanical stability and signaling between the extracellular and intracellular compartments.
Laminin-211 binds to integrin α7β1 on muscle fibers:
- Activates focal adhesion kinase (FAK)
- Triggers PI3K/Akt survival signaling
- Promotes cell adhesion and spreading
- Regulates muscle fiber stability
In peripheral nerve, laminin-211:
- Promotes Schwann cell differentiation
- Supports myelination program activation
- Maintains myelin sheath integrity
- Regulates nodal architecture
Therapeutic strategies for LAMA2-related disorders include [lamarelated2019]:
- Gene therapy: Viral delivery of functional LAMA2 (AAV vectors being developed)
- Exon skipping: Antisense oligonucleotides targeting specific mutations
- Laminin supplementation: Recombinant laminin fragments
- Small molecule modulators: Compounds that enhance residual protein function
- Cell therapy: Stem cell transplantation approaches
Research challenges:
- Large gene size complicates gene therapy delivery
- Blood-brain barrier limits CNS delivery
- Immune responses to exogenous protein
- Timing of intervention is critical (early treatment preferred)
LAMA2-deficient mouse models (dy/dy mice) have been instrumental in understanding the disease:
- Spontaneous dy/dy mouse: Natural mutation causing severe muscular dystrophy
- dy2J mice: Milder model with later onset
- Conditional knockouts: Tissue-specific models for mechanistic studies
These models demonstrate:
- Progressive muscle degeneration
- Demyelinating peripheral neuropathy
- Impaired nerve regeneration
- CNS white matter abnormalities
While LAMA2 is primarily known for its role in muscular dystrophy, emerging research suggests potential connections to Alzheimer's disease pathogenesis [yan2019]:
Blood-Brain Barrier Function: Laminin-211 is a critical component of the vascular basement membrane at the BBB:
- Maintains endothelial tight junction integrity
- Supports astrocyte end-foot polarization
- Regulates pericyte function and coverage
- BBB dysfunction is an early feature in AD
Synaptic Integrity: LAMA2 contributes to synaptic maintenance in the adult brain [rao2018]:
- Laminin in the synaptic cleft regulates receptor trafficking
- Affects long-term potentiation and memory consolidation
- Loss of laminin may contribute to synaptic dysfunction in AD
- Promotes dendritic spine formation and maintenance
LAMA2 may play roles in Parkinson's disease through several mechanisms:
Dopaminergic Neuron Support: The substantia nigra contains laminin-211 that:
- Supports dopaminergic neuron survival
- Modulates neuroinflammation
- May be altered in PD brains
Peripheral Nerve Involvement: Given the PNS manifestations in LAMA2 deficiency:
- May contribute to autonomic dysfunction in PD
- Could affect gastrointestinal manifestations
LAMA2 has been studied in demyelinating conditions:
- Myelin repair processes require laminin-211
- Oligodendrocyte precursor migration depends on laminin interactions
- Remyelination strategies targeting laminin are under investigation [wang2020]
Laminin-211 activates multiple intracellular signaling pathways through integrin binding [johnson2021]:
FAK Activation:
- Focal adhesion kinase autophosphorylation
- Activation of Src family kinases
- Downstream MAPK/ERK signaling
PI3K/Akt Pathway:
- Pro-survival signaling
- Protein synthesis regulation
- Anti-apoptotic gene expression
- Critical for muscle fiber survival
Rho GTPase Regulation:
- Cytoskeletal organization
- Cell migration
- Dendritic spine morphology
The dystrophin-glycoprotein complex provides mechanical protection:
- Distributes forces across the sarcolemma
- Prevents membrane damage during contraction
- Coordinates signaling with cytoskeletal proteins
Laminin-211 turnover is carefully regulated [taylor2021]:
- Matrix metalloproteinases (MMPs) cleave laminin
- MMP-2 and MMP-9 are elevated in LAMA2-related diseases
- Balance between deposition and degradation is critical
Viral delivery of functional LAMA2 is actively being developed [davis2024]:
- AAV vectors can accommodate the LAMA2 cDNA
- Muscle-targeted delivery shows promise
- CNS delivery remains challenging due to BBB
- Combining muscle and nervous system targeting
Small molecule strategies include [park2024]:
- Corticosteroids for inflammation management
- Myostatin inhibitors to enhance muscle mass
- Laminin fragment supplementation
- Integrin agonists
- Mesenchymal stem cell transplantation
- Ex vivo gene correction
- Muscle progenitor cell delivery
Laminin-211 interacts with other laminin isoforms [smith2020]:
| Isoform |
Tissue Distribution |
Functional Relationship |
| Laminin-111 |
Embryonic |
Temporal expression pattern |
| Laminin-411 |
Vascular |
BBB maintenance |
| Laminin-511 |
Epithelial |
Tissue-specific functions |
- Muscle biopsy with immunostaining
- Genetic testing for LAMA2 mutations
- MRI for white matter abnormalities
- Nerve conduction studies
¶ Standard of Care
- Physical therapy for contracture prevention
- Respiratory support as needed
- Cardiac monitoring
- Orthopedic interventions
- Serum laminin-211 levels as disease marker
- Genetic modifiers of phenotype
- Biomarkers for therapeutic response
- Newborn screening for LAMA2 mutations
- Early intervention protocols
- Family genetic counseling